Cargando…
Immunogenic epitope panel for accurate detection of non-cross-reactive T cell response to SARS-CoV-2
The ongoing COVID-19 pandemic calls for more effective diagnostic tools. T cell response assessment serves as an independent indicator of prior COVID-19 exposure while also contributing to a more comprehensive characterization of SARS-CoV-2 immunity. In this study, we systematically assessed the imm...
Autores principales: | Titov, Aleksei, Shaykhutdinova, Regina, Shcherbakova, Olga V., Serdyuk, Yana V., Sheetikov, Savely A., Zornikova, Ksenia V., Maleeva, Alexandra V., Khmelevskaya, Alexandra, Dianov, Dmitry V., Shakirova, Naina T., Malko, Dmitry B., Shkurnikov, Maxim, Nersisyan, Stepan, Tonevitsky, Alexander, Khamaganova, Ekaterina, Ershov, Anton V., Osipova, Elena Y., Nikolaev, Ruslan V., Pershin, Dmitry E., Vedmedskia, Viktoria A., Maschan, Michael, Ginanova, Victoria R., Efimov, Grigory A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090254/ https://www.ncbi.nlm.nih.gov/pubmed/35389886 http://dx.doi.org/10.1172/jci.insight.157699 |
Ejemplares similares
-
SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors
por: Shomuradova, Alina S., et al.
Publicado: (2020) -
Transgenic HA-1-Specific CD8(+) T-Lymphocytes Selectively Target Leukemic Cells
por: Pilunov, Artem, et al.
Publicado: (2023) -
Clonal diversity predicts persistence of SARS-CoV-2 epitope-specific T-cell response
por: Zornikova, Ksenia V., et al.
Publicado: (2022) -
Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia
por: Lioznov, Dmitry, et al.
Publicado: (2023) -
Rapid Multiplex Genotyping of 20 HLA-A(*)02:01 Restricted Minor Histocompatibility Antigens
por: Romaniuk, Dmitrii S., et al.
Publicado: (2019)